MDMA drug developer Lykos Therapeutics has changed its name to Resilient Pharmaceuticals, Inc., Psychedelic Alpha understands. The move comes after British investor and philanthropist Sir Chris Hohn and Musk ally Antonio Gracias teamed up to inject fresh funding into the ailing company, which suffered an FDA rejection last Summer. That $50M recapitalisation…
